Bruker Corporation (NASDAQ:BRKR) went up by 1.36% from its latest closing price compared to the recent 1-year high of $76.70. The company’s stock price has collected 4.05% of gains in the last five trading sessions. Press Release reported on 06/21/21 that Novel 4D-Metabolomics and 4D-Lipidomics Workflows, Libraries and ML-based CCS Prediction Tools to Transform Metabolomics and Lipidomics
Is It Worth Investing in Bruker Corporation (NASDAQ :BRKR) Right Now?
Bruker Corporation (NASDAQ:BRKR) scored a price-to-earnings ratio above its average ratio, recording 58.54 x from its present earnings ratio. Plus, the 36-month beta value for BRKR is at 1.28. Opinions of the stock are interesting as 4 analysts out of 13 who provided ratings for Bruker Corporation declared the stock was a “buy,” while 0 rated the stock as “overweight,” 8 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $73.85, which is -$2.56 below the current price. BRKR currently public float of 102.05M and currently shorts hold a 1.52% ratio of that float. Today, the average trading volume of BRKR was 687.20K shares.
BRKR’s Market Performance
BRKR stocks went up by 4.05% for the week, with a monthly jump of 13.16% and a quarterly performance of 14.95%, while its annual performance rate touched 86.89%. The volatility ratio for the week stands at 1.66% while the volatility levels for the past 30 days are set at 2.30% for Bruker Corporation. The simple moving average for the period of the last 20 days is 5.65% for BRKR stocks with a simple moving average of 33.29% for the last 200 days.
Analysts’ Opinion of BRKR
Wells Fargo, on the other hand, stated in their research note that they expect to see BRKR reach a price target of $55, previously predicting the price at $50. The rating they have provided for BRKR stocks is “Equal Weight” according to the report published on February 05th, 2021.
Goldman gave a rating of “Sell” to BRKR, setting the target price at $50 in the report published on December 02nd of the previous year.
BRKR Trading at 9.88% from the 50-Day Moving Average
After a stumble in the market that brought BRKR to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 1.12% of gains for the given period.
Volatility was left at 2.30%, however, over the last 30 days, the volatility rate increased by 1.66%, as shares surge +11.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.01% upper at present.
During the last 5 trading sessions, BRKR rose by +4.05%, which changed the moving average for the period of 200-days by +100.93% in comparison to the 20-day moving average, which settled at $73.81. In addition, Bruker Corporation saw 43.28% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at BRKR starting from Friend Cynthia M, who sale 1,800 shares at the price of $60.43 back on Mar 22. After this action, Friend Cynthia M now owns 8,686 shares of Bruker Corporation, valued at $108,766 using the latest closing price.
Kastner Marc A, the Director of Bruker Corporation, sale 1,236 shares at $56.56 during a trade that took place back on Jan 07, which means that Kastner Marc A is holding 11,146 shares at $69,908 based on the most recent closing price.
Stock Fundamentals for BRKR
Current profitability levels for the company are sitting at:
- +13.81 for the present operating margin
- +47.48 for the gross margin
The net margin for Bruker Corporation stands at +7.94. The total capital return value is set at 14.81, while invested capital returns managed to touch 8.73. Equity return is now at value 21.60, with 6.90 for asset returns.
Based on Bruker Corporation (BRKR), the company’s capital structure generated 94.96 points at debt to equity in total, while total debt to capital is 48.71. Total debt to assets is 29.94, with long-term debt to equity ratio resting at 92.52. Finally, the long-term debt to capital ratio is 47.45.
When we switch over and look at the enterprise to sales, we see a ratio of 4.31, with the company’s debt to enterprise value settled at 0.11. The receivables turnover for the company is 5.08 and the total asset turnover is 0.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.43.